NPPA slaps over Rs 6L demand notice to Torrent Pharma
The demand notice is for the launch of a new drug wherein price approval was taken after the launch, Torrent Pharma said in a regulatory filing.
Written By : Farhat Nasim
Published On 2024-10-19 10:02 GMT | Update On 2024-10-19 10:02 GMT
Advertisement
New Delhi: Torrent Pharmaceuticals on Friday said it has received a demand notice of Rs 6.32 lakh from the National Pharmaceutical Pricing Authority (NPPA). The company has received the notice from NPPA under paragraph 15 of Drug Price Control Order 2013, imposing a penalty of Rs 6,32,689.
The demand notice is for the launch of a new drug wherein price approval was taken after the launch, the drug firm said in a regulatory filing.
The said order does not have any material financial impact on the company, it added.
The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of medicines in the country.
It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.
The regulator implements and enforces the provisions of the Drugs (Prices Control) Order.
It is also entrusted with the task of recovering amounts overcharged by manufacturers for controlled drugs from consumers.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.